CTSI Accelerator collaborates with partners at Duke and other institutions to provide researchers with funding opportunities for the entire translational spectrum.
View past pilot projects supported by the Pilot Funding Program.
Contact CTSI Accelerator for personalized help with translational research funding and project management.
Funding programs that are currently accepting applications are marked open.
CTSI Accelerator Funding Programs
This funding mechanism aims to develop practical, generalizable, and scalable solutions that enhance the participant experience in research. These solutions should improve trust, engagement, satisfaction, and retention, ensuring participants feel valued as partners in the research process.
The program is accepting applications for two 12-month funding cycles and will award up to eight grants per cycle, each providing $25,000 to $50,000 in direct costs. Funding is provided through the Duke Clinical and Translational Science Award (CTSA).
Mandatory LOI Deadline: 5:00 pm ET, December 5, 2025
Full Application Deadline: 5:00 pm ET, January 15, 2026
Current Status: Open
This funding mechanism aims to develop innovative, generalizable solutions that improve efficiency, effectiveness, and impact of the translational research process. Solutions developed under this mechanism are expected to have broad relevance and impact across multiple disease states.
The program is accepting applications for two 12-month funding cycles and will award up to eight grants per cycle, each providing $25,000 to $50,000 in direct costs. Funding is provided through the Duke Clinical and Translational Science Award (CTSA).
Mandatory LOI Deadline: 5:00 pm ET, December 5, 2025
Full Application Deadline: 5:00 pm ET, January 15, 2026
Current Status: Open
As a CTSA Hub, Duke University is eligible to apply for the High Impact Specialized Innovation Programs (SIPs) in Clinical and Translational Science (RC2, Clinical Trials Optional) (PAR-25-156). The goal of this program is to support “the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a timely manner critical gap areas and/or roadblocks in clinical and translational science.”
This funding mechanism supports research to improve the functioning and performance of collaborations within clinical and translational research. The program seeks approaches to strengthening collaboration across the translational research spectrum, with the goal of supporting more efficient, effective, and impactful translational research that shortens the time from scientific discovery to health impact.
The program is accepting applications for one 24-month funding cycle, which will confer $125,000 per year in direct costs. Funding is provided through the Duke Clinical and Translational Science Award (CTSA).
Full Application Deadline: 5:00 pm ET, June 1, 2026
Current Status: Open
View the RFA
Have questions or don't see a funding opportunity that fits your needs?
CTSI Accelerator's team of funding and project management experts can help.